Category: Arthritis News

Thinking Differently for MSK Health Conference

Monday 6 December 2021
Online interactive conference

Andrew BennettAndrew Bennett

National Clinical Director MSK, NHS England

The role of the ICS and Place
in MSK service improvement
– National perspective slides

Andrew is National Clinical Director for Musculoskeletal Conditions for NHS England and Improvement, and a Consultant Physiotherapist at Sutton Health and Care Alliance, Epsom and St Helier NHS Trust. He qualified in 2000 in Leeds, completing specialty training across London as well as a PGcert, PGdip and MSc. He led the successful re design of MSK local services presented nationally and internationally, is a lead for MSK transformation within the South West London Health and Care Partnership and acted an expert specialist for a variety of projects including the recent NIHR Moving Forward themed review.…

Read more of this article

MSK leading the way

by Sue Brown, CEO, ARMA

It’s been fantastic over the last few months to work with ARMA members to rise to the challenge of the Covid-19 pandemic. We now have to rise to a new challenge – resetting MSK services to be more personalised and to use shared decision making to ensure people receive the right treatment efficiently and effectively. ARMA’s vision for MSK and that discussed at the NHS England MSK leadership meetings are remarkably similar. Making that vision a reality will take the combined effort of all of us.…

Read more of this article

Women and young people hit hardest by lockdown

Study suggests women and young people have been hardest hit psychologically by coronavirus lockdown

A new study, published in The Lancet Psychiatry, has looked at the potential impact of the coronavirus pandemic on population mental health.

  • It found that there was an overall increase in mental distress in people aged 16 years and older in the UK.
  • This did not affect all groups equally, with some subgroups showing marked increases. Factors most strongly linked with mental health deterioration were those associated with pre-existing health inequalities, such as gender and age.
…

Read more of this article

Gold Standard Time to Diagnosis

Help end the 8.5-year delay in the diagnosis of axial SpA (AS)

A new programme that aims to end the 8.5-year delay to diagnosis for people living with axial Spondyloarthritis (axial SpA) was launched on 15 July 2020.

Gold Standard Time to Diagnosis will set the world’s first Gold Standard to reduce the average time to diagnosis in axial SpA (AS) to just one year. The consultation process, which is phase one of the programme, was launched at the All-Party Parliamentary Group on axial Spondyloarthritis.…

Read more of this article

Launch of brand new JIA-at-NRAS website

Since 2019, NRAS has been working hard on improving information provision to members, supporters and the wider Juvenile Idiopathic Arthritis (JIA) community. 

The latest publications, updates and activities for JIA-at-NRAS represent a huge support resource for those who need it. A priority for NRAS – and an expectation from those they support – is an easy-to-navigate, user friendly, informational website, because this is the primary route for people to discover the organisation.

NRAS is excited to launch the new and improved JIA-at-NRAS website!…

Read more of this article

NICE publishes new guidelines on elective surgery, planned care

A new COVID-19 rapid guideline: arranging planned care in hospitals and diagnostic services NICE guideline [NG179] has been released by NICE. The publication makes recommendations for how these services should be organised to balance the risks associated with covid-19 and the potential harms that could arise from delays in elective treatment and diagnostic procedures.

The guidance states that people having planned care involving any form of anaesthesia and sedation should follow social distancing and hand hygiene measures for 14 days prior to admission – a change from 14 days of self-isolation.…

Read more of this article

Versus Arthritis launches ‘Impossible to Ignore’ campaign

People with arthritis can’t ignore their pain. Let’s make sure the Government doesn’t, either. 

This is why Versus Arthritis has launched the Impossible to Ignore campaign, calling on politicians and policy-makers to address the needs of people with arthritis. Now, your support is needed to demand change.

For many people, lockdown has made living with arthritis even harder. With appointments, treatments and joint replacement surgery delayed, people with arthritis face worsening pain and impacts to their physical and mental health that are impossible to ignore. …

Read more of this article

ARMA’s new Associate Membership Scheme

ARMA has launched a new Associate Membership scheme to enable a wider range of stakeholders to engage with our activities.

It is important that our work is driven by the needs of patients, clinicians and researchers and is independent of commercial interests. However, we recognise that there are many stakeholders not eligible for ARMA membership who play an important role in musculoskeletal health, whose involvement would be mutually beneficial. Associate membership of ARMA provides a way for such organisations to engage with our work.…

Read more of this article

BOA Policy update – July 2020

report coverThe report emergent from Baroness Cumberlege and the Independent Medicines and Medical Devices Safety review was published in early July and has been welcomed by the British Orthopaedic Association. This comprehensive review has demonstrated the impact on the physical and mental health of patients when implants fail. The review shows that there is a clear need for detailed surveillance of implants, and we welcome the recommendation for the establishment of more National Implant Registries.

Read the BOA’s full position on this issue.…

Read more of this article